Dr. Boardman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511
Summary
- Dr. Lisa Boardman is a gastroenterologist in Rochester, MN and is affiliated with Mayo Clinic Hospital - Rochester. She received her medical degree from Wake Forest School of Medicine and has been in practice 26 years. She specializes in gastrointestinal cancer and is experienced in general gastroenterology, colorectal polyps, gastrointestinal oncology, dna methylation, and gene expression profiling.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gastroenterology, 1994 - 1998
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1992 - 1994
- University of FloridaInternship, Internal Medicine, 1991 - 1992
- Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1991
Certifications & Licensure
- MN State Medical License 1992 - 2025
- FL State Medical License 1996 - 2013
- American Board of Internal Medicine Gastroenterology
Clinical Trials
- Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome Start of enrollment: 2023 May 08
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Gastric polyposis and risk of gastric cancer in patients with familial adenomatous polyposis.Rachel V Christenson, Shubham Sood, Robert A Vierkant, Daniel Schupack, Lisa Boardman
Journal of Gastrointestinal Surgery. 2024-11-01 - 3 citationsGenomic landscape of diploid and aneuploid microsatellite stable early onset colorectal cancer.Yumei Zhou, Xianfeng Chen, Jun Chen, Conner D Kendrick, Ramesh K Ramanathan
Scientific Reports. 2024-04-23 - Epidemiologic Factors in Relation to Colorectal Cancer Risk and Survival by Genotoxic Colibactin Mutational Signature.Claire E Thomas, Peter Georgeson, Conghui Qu, Robert S Steinfelder, Daniel D Buchanan
Cancer Epidemiology, Biomarkers & Prevention. 2024-04-03
Journal Articles
- Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing CholangitisDavid H Bruining, Julie K Heimbach, Lisa Boardman, Laura E Raffals, Charles B Rosen, Sunanda V Kane, Kymberly D Watt, John J Poterucha, Inflammatory Bowel Diseases
Press Mentions
- Can Colorectal Cancer Be Prevented?December 7th, 2022
- April 2021: CRC Research & ResourcesApril 7th, 2021
- Study Examines Which Polyps Lead to Colon CancerApril 7th, 2018
- Join now to see all
Grant Support
- Telomere Length, Telomere Maintenance Genes And Cancer RiskNational Cancer Institute2008–2011
- Molecular Basis Of Young Onset Colorectal CancerNational Cancer Institute2004–2006
- Molecular Basis Of Young Onset Colorectal CancerNational Cancer Institute2002–2003
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: